<DOC>
	<DOCNO>NCT00054756</DOCNO>
	<brief_summary>This study determine safety activity new formulation thyrotropin-releasing hormone ( TRH ) , drug use diagnose evaluate patient certain thyroid gland abnormality . Normal thyroid gland function depend proper chemical signal thyroid gland , hypothalamus ( part brain TRH make ) , pituitary ( another part brain ) . The TRH test help assess interaction . Production FDA-approved preparation TRH stop July 2002 . As result , continuous source TRH available NIH clinical research purpose , NIH Clinical Center ( CC ) Pharmacy Department produce pharmaceutical grade formulation TRH patient use . This study test CC formulation healthy volunteer show activity side effect similar previously available commercial test preparation . It study CC patient diagnostic test recommend . Healthy volunteer 18 65 year age patient require TRH evaluation hypothalamic-pituitary-thyroid gland interaction may eligible study . Patients include pituitary reserve , inconsistent thyroid function test , inappropriate TSH secretion , pre- post-operative evaluation pituitary tumor . Normal volunteer screen medical history , physical examination , blood test . Women child-bearing potential give pregnancy test ; pregnant breast-feeding woman may participate . The TRH test procedure healthy volunteer patient . All participant fast midnight morning test . In morning , catheter ( flexible plastic tube ) insert arm vein easy injection TRH collection blood sample . Blood pressure monitor test . A blood sample drawn , TRH give catheter 1-minute period . Another nine blood sample collect 3-hour period time TRH injection measuring level various hormone . A total less 4 tablespoon blood take test .</brief_summary>
	<brief_title>Study Thyrotropin-Releasing Hormone Normal Volunteers Patients With Thyroid Pituitary Abnormalities</brief_title>
	<detailed_description>Thyrotropin release hormone ( TRH ) neuropeptide use diagnostic evaluation patient dysfunction hypothalamic-pituitary-thyroid ( HPT ) axis . In healthy individual , administration TRH intravenously result pituitary secretion thyrotropin [ thyroid-stimulating hormone ( TSH ) ] , turn stimulates thyroid gland release thyroid hormone ; thyroxine ( T4 ) triiodothyronine ( T3 ) . TRH stimulate secretion pituitary hormone normal physiologic well pathologic condition . Under protocol , TRH use routine diagnostic test research study adults child . It produce Pharmaceutical Development Section Clinical Center Pharmacy NIH . The safety , activity comparability preparation demonstrate small group normal volunteer prior release diagnostic research use .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Pituitary Diseases</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Thyrotropin-Releasing Hormone</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>DIAGNOSTIC STUDY PROTOCOL All adult child require dynamic test hypothalamicpituitary axis evaluation pituitary reserve , inconsistent thyroid function test , inappropriate TSH secretion , preand postoperative evaluation pituitary adenoma ( glycoprotein hormone secrete tumor , growth hormone secrete tumor TSH secrete tumor ) . Uncontrolled hypertension ; Uncontrolled seizure disorder ; Unstable coronary disease ; Known allergy TRH . RESEARCH PROTOCOLS TRH available use IRB approve research protocol either use standard diagnostic test protocol modify TRH test . Untreated hypertension ; Coronary artery disease ; History asthma ; History seizures ; Pregnancy ; Known allergy TRH .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 3, 2017</verification_date>
	<keyword>Hypothalamic Releasing Factor</keyword>
	<keyword>Neuropeptide</keyword>
	<keyword>Diagnostic Testing</keyword>
	<keyword>Pituitary Tumors</keyword>
	<keyword>Central Hypothyroidism</keyword>
	<keyword>Pituitary Disorder</keyword>
	<keyword>Thyroid Disorder</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>